Drug Profile
S 8115
Latest Information Update: 29 May 2001
Price :
$50
*
At a glance
- Originator Mundipharma International
- Developer Shionogi
- Class Analgesics
- Mechanism of Action Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer pain
Most Recent Events
- 29 May 2001 Discontinued-III for Cancer pain in Japan (Unknown route)
- 26 Jun 2000 Suspended-III for Cancer pain in Japan (Unknown route)
- 14 Jan 1998 New profile